INTRODUCTION
============

Apoptosis is a programmed cell death in multicellular organisms, employed for the development and maintenance of homeostasis, and removal of damaged cells [@B001]. It has been demonstrated that caspases play a pivotal role in apoptosis [@B002]. Caspases cleave their substrates after aspartic acid at P1 sites, by using cysteine residue in the catalytic site [@B003]. P4-P1 residue in the target proteins determines the substrate specificity of caspases [@B004],[@B005]. In apoptosis, caspases are classified into initiator caspases and executioner caspases [@B006]. Once the extrinsic death signal is given by the ligand-induced activation of death receptors, initiator caspase-8 and caspase-10 are activated by dimerization [@B007],[@B008]. The death signal is delivered by an internal factor, such as DNA damage, and the release of cytochrome c from the mitochondria induces the formation of the apoptosome. Initiator caspase-9 is recruited to the apoptosome complex, and activated by dimerization [@B009]. In turn, this activated initiator caspases activate the executioner caspases. The activated executioner caspases cleave their specific target proteins [@B010]. Executioner caspases include caspase-3, -7 and caspase-6. Among them, it has been well known that caspase-3 cleaves a large set of substrates, and plays a major role in apoptosis [@B011],[@B012]. Caspase-7, sharing the high sequence homology with caspase-3, recognizes the same cleavage site of caspase-3 [@B004],[@B013], suggesting that caspase-3 and -7 have redundant roles [@B011]. However, caspase-6 has somewhat unique roles as an executioner in apoptosis. Caspase-6 prefers leucine or valine at the P4 position, whereas caspase-3 and -7 prefer aspartate at the P4 position in target substrates [@B014],[@B015]. Therefore, caspase-6 has unique substrates that are not cleaved by either caspase-3 or caspase-7, such as lamin A/C [@B016], special AT-rich binding protein-1 (SATB1) [@B017], the neurodegenerative disease proteins Huntingtin [@B018], amyloid precursor protein [@B019], Presenilin 1, 2 [@B020], and DJ-1 [@B021]. The most distinctive feature of caspase-6 is that it is activated by caspase-3 and -7 [@B022], and inversely activates caspase-3 and -7 [@B023]. Also, caspase-6 acts as an initiator caspase, by processing initiator caspase-8 and -10 during apoptosis [@B022],[@B024]. Although the role of caspase-6 has been proposed in a number of reports, its substrates and its function are still unclear during apoptosis.

Thus, to better understand the biological roles of caspase-6 during apoptosis, we carried out proteomic analyses to seek for novel sets of caspase-6 substrates. In our present study, we report novel putative 34 substrates for caspase-6, and show that 5 of them, HAUSP, Kinesin5B, GEP100, SDCCAG3, and PARD3, are directly cleaved by caspase-6 during apoptosis.

RESULTS AND DISCUSSION
======================

Screening of putative substrates for caspase-6 by proteomic approaches
----------------------------------------------------------------------

To seek for novel caspase-6 substrates, we performed two-dimensional gel electrophoresis based proteomics analyses ([Fig. 1](#F0001){ref-type="fig"}A). HepG2, a human hepatoma cell line was used, since HepG2 cells have not been studied to screen for caspase substrates [@B014]. To increase the possibility of finding more candidates in 2DE analyses, HepG2 cell extract was fractionated into cytosol, membrane and nucleus fractions, and each subcellular fraction was incubated with either recombinant active caspase-6 or catalytic mutant substituted 163-cysteine into serine in active site (inactive caspase-6). Then, incubated proteins were separated by isoelectric focusing and SDS-PAGE ([Fig. 1](#F0001){ref-type="fig"}A). The experiments were repeated three times, independently, to establish reproducibility. By comparing two-dimensional gel images of active caspase-6 and inactive caspase-6 mutant, appeared or disappeared protein spots were selected. Consequently, we found different 39 spots in cytosolic ([Fig. 1](#F0001){ref-type="fig"}B), 33 spots in membrane ([Fig. 1](#F0001){ref-type="fig"}C), and 62 spots in nucleus fraction ([Fig. 1](#F0001){ref-type="fig"}D). These protein spots were identified by MALDI-TOF- MS analysis. To obtain reliable results, proteins that have ＞95% confidence level in the Mascot program (Matrix Science) were selected. To determine whether the identified candidates were novel or not, we carried out a database search at The CASBAH (<http://bioinf.gen.tcd.ie/casbah>) and the CutDB, a proteolytic event database (<http://cutdb.burnham.org>), and a literature search at Pubmed. Finally, we obtained a list of novel candidates of caspase-6 substrates ([Table 1](#T0001){ref-type="table"}). It is worth noting that the representative caspase-6 substrates, such as lamin A/C, vimentin, actin, tubulin, and ezrin, were identified in our screening system indicating that our screening method was functioning properly ([Table 1](#T0001){ref-type="table"}).

HAUSP, Kinesin5B, GEP100, SDCCAG3 and PARD3 are directly cleaved by caspase-6 in vitro
--------------------------------------------------------------------------------------

In order to confirm whether the candidate proteins listed in [Table 1](#T0001){ref-type="table"} would be cleaved by caspase-6, we performed the *in vitro* cleavage assay. HepG2 cell extracts were incubated with either active caspase-6, or catalytic mutant caspase-6. The cleavage was detected by western blotting, using the specific antibodies. Eight candidate proteins (HAUSP, Kinesin 5B, GEP100, SDCCAG3, PARD3, CLK3, ADH4, and MDH1), of which commercial antibodies are available, were tested. Lamin A/C, a well known caspase-6 substrate, was used as a positive control. As a result, the level of HAUSP, Kinesin 5B, GEP100, SDCCAG3 and PARD3 reduced only when active caspase-6 was treated. This indicates that these proteins were cleaved directly by caspase-6, according to Lamin A/C cleavage ([Fig. 2](#F0002){ref-type="fig"}A). However, these cleavages were blocked in the presence of caspase-6 inhibitor, Z-VEID-FMK ([Fig. 2](#F0002){ref-type="fig"}A). Therefore, these results indicate that HAUSP, Kinesin5B, GEP100, SDCCAG3 and PARD3 are directly cleaved by caspase-6. On the other hand, CLK3, ADH4 and MDH1 were not cleaved by caspase-6, even though twice the amounts of caspase-6 were used ([Fig. 2](#F0002){ref-type="fig"}B), implying that CLK3, ADH4 and MDH1 are not direct substrates for caspase-6.

![(A) The workflow for screening to identify novel caspase-6 substrates by proteomics approaches. (B-D) 2-DE gel images showing the differentially displayed spots. (B) Cytosol fractions, (C) membrane fractions, or (D) nucleus fractions, treated with either active caspase-6 or inactive casspase-6, were analyzed using 2-DE. The experiments were repeated for three times, independently. The representative gel images are shown.](BMB-46-588-g0001){#F0001}

###### 

Identified proteins from 2DE-Proteomics and MALDI-TOF-MS analysis

  ---------- ---------- ------------------------------------------------------------------------------------------ --------------- --------------- ----------------- ----------------- ----------------------- ----------------------- ------
  Fraction   Spot no.   Identified protein description                                                             Symbol          Accession no.   Mascot score^a^   Matched peptide   Sequence coverage (%)   Molecular weight (Da)   pI
                                                                                                                                                                                                                                       
  Cytosol    2          Dual specificity protein kinase CLK3                                                       CLK3            gi\|194097436   67                13                28                      74,267                  9.94
             5          Tryptophanyl-Trna Synthetase                                                               WARS            gi\|50513261    66                13                27                      43,586                  7.12
             9          Chain A, Human Ubiquitous Kinesin Motor Domain                                             Kinesin5B       gi\|157830287   66                9                 40                      36,792                  5.88
             11         Actin, cytoplasmic 1                                                                       Beta-actin      gi\|4501885     748               24                29                      42,052                  5.29
             12         Alpha-actin                                                                                Alpha-actin     gi\|178027      118               2                 7                       42,480                  5.23
             21         GTP-binding protein Rit1 isoform 2                                                         Rit1            gi\|5902050     67                10                55                      25,357                  9.2
             24         Serologically defined colon cancer antigen 3                                               SDCCAG3         gi\|55961008    66                9                 69                      18,921                  5.74
  Membrane   2          IQ motif and Sec7 domain 1                                                                 GEP100          gi\|119584552   66                15                24                      121,073                 9.2
             8          Herpesvirus associated ubiquitin-specific protease                                         HAUSP           gi\|1545952     70                20                20                      129,274                 5.33
             10         Tubulin, gamma complex associated protein 2 variant                                        TUBGCP2         gi\|62898904    67                16                27                      103,011                 6.38
  Nucleus    3          Alpha-tubulin                                                                              Alpha-tubulin   gi\|340021      90                14                35                      50,804                  4.94
             5          Antigen identified by monoclonal antibody Ki-67                                            Ki-67           gi\|119569563   76                32                14                      360,616                 9.48
             6          Translin-associated factor X interacting protein 1                                         TSNAX           gi\|119603582   67                14                25                      72,374                  5.11
             9          Dynein, axonemal, heavy polypeptide 1                                                      DNAH1           gi\|119585621   70                32                10                      497,514                 5.62
             10         Gephyrin                                                                                   Gephyrin        gi\|16605466    67                14                33                      80,410                  5.25
             11         Olfactomedin-like protein 1 precursor                                                      OLFL1           gi\|284172520   66                11                41                      46,378                  8.29
             12         Alcohol dehydrogenase 4                                                                    ADH4            gi\|825623      67                9                 41                      41,094                  8.25
             13         Actin, beta, partial                                                                       Beta-actin      gi\|14250401    70                13                52                      41,321                  5.56
             15         Peroxisomal bifunctional enzyme isoform 1                                                  EHHADH          gi\|68989263    66                12                25                      80,072                  9.24
             16         PR domain containing 5                                                                     PRDM5           gi\|119625672   66                12                36                      50,017                  9.49
             20         Regulatory factor X, 5 (influences HLA class II expression)                                RFX5            gi\|122889236   67                13                31                      63,473                  9.41
             21         KIAA0524SARM protein                                                                       \-              gi\|7711002     67                12                26                      76,260                  8.58
             22         Partitioning-defective 3-like protein splice variant c                                     PARD3           gi\|18874468    66                16                19                      125,435                 8.57
             24         Dynein, axonemal, heavy polypeptide 1                                                      DNAH1           gi\|119585622   67                21                12                      280,703                 5.74
             25         Kinesin-like protein KIF16B                                                                KIF16B          gi\|41327691    74                23                19                      152,488                 5.86
             25         Ezrin                                                                                      Ezrin           gi\|46249758    64                17                25                      69,313                  5.94
             26         Cytoplasmic linker associated protein 1                                                    CLASP1          gi\|119615659   66                15                23                      102,275                 9.53
             27         Adenosine deaminase                                                                        ADA             gi\|1197210     67                11                42                      35,335                  5.6
             28         Herpesvirus associated ubiquitin-specific protease                                         HAUSP           gi\|1545952     112               26                24                      129,274                 5.33
             29         Alpha tubulin                                                                              Alpha-tubulin   gi\|109093209   72                13                40                      46,767                  5.01
             30         Bullous pemphigoid antigen 1                                                               BPAG1           gi\|27923959    69                34                12                      374,544                 6.38
             31         Vimentin                                                                                   VIM             gi\|62414289    70                16                27                      53,676                  5.06
             33         Inter-alpha-trypsin inhibitor family heavy chain-related protein                           IHRP            gi\|1483187     97                21                28                      103,549                 6.51
             34         Lamin A/C                                                                                  LMNA            gi\|21619981    193               27                40                      53,222                  6.03
             35         Lamin A/C                                                                                  LMNA            gi\|21619981    107               19                30                      53,222                  6.03
             37         GT mitochondrial solute carrier protein homologue; putative, partial                       \-              gi\|386960      66                9                 37                      38,645                  9.9
             38         MIF4G domain-containing protein isoform 2                                                  MIF4GD          gi\|23510352    66                7                 33                      29,941                  5.29
             39         Actin, cytoplasmic 2-like                                                                  ACTG1           gi\|354468985   111               17                62                      28,478                  5.2
             40         Actin, beta                                                                                Beta-actin      gi\|14250401    126               19                44                      41,321                  5.56
             43         Glutaryl-Coenzyme A dehydrogenase                                                          GCDH            gi\|119604731   67                11                38                      47,923                  8.73
             47         Malate dehydrogenase 1B                                                                    MDH1            gi\|89886456    71                13                22                      59,013                  5.85
             49         ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle   ATP5A           gi\|15030240    66                13                28                      59,886                  9.07
             52         Protein FAM73A                                                                             FAM73A          gi\|38348384    67                13                33                      71,930                  5.42
             56         Rab GDP dissociation inhibitor beta isoform 1                                              GDI2            gi\|6598323     67                10                44                      51,087                  6.11
             57         WD repeat domain 18                                                                        WDR18           gi\|12804481    67                11                28                      47,960                  6.22
             58         Coiled-coil domain-containing protein 148                                                  CCDC148         gi\|76779830    66                8                 42                      33,401                  7.63
             63         ATP/GTP binding protein-like 3                                                             AGBL3           gi\|22658305    67                14                31                      73,571                  7.22
  ---------- ---------- ------------------------------------------------------------------------------------------ --------------- --------------- ----------------- ----------------- ----------------------- ----------------------- ------

^a^proteins scores are significant at 95% confidence level.

Candidate proteins were proteolytically processed by caspases during apoptosis
------------------------------------------------------------------------------

Then we performed the *in vivo* cleavage assay to verify whether the candidates would be cleaved *in vivo* during apoptosis. HeLa cells were treated with staurosporine (STS), which induces apoptosis by inhibiting cellular protein kinase [@B025]. Apoptosis was confirmed by observing of PARP cleavage ([Fig. 3](#F0003){ref-type="fig"}A and [3](#F0003){ref-type="fig"}B), which is a well-established apoptosis hallmark, and is also a caspase-3 and caspase-7 substrate [@B026],[@B027]. To examine the specificity of caspases, three different caspase inhibitors (Z-VEID-FMK; caspase-6 inhibitor, Z-DEVD-FMK; caspase-3/-7 inhibitor and Z-VAD-FMK; pan-caspase inhibitor) were treated together with STS. In STS stimulated HeLa cells, all candidate proteins (HAUSP, Kinesin5B, GEP100, SDCCAG3, and PARD3) were processed ([Fig. 3](#F0003){ref-type="fig"}A). In the presence of Z-VEID-FMK and STS, the cleavage of Kinesin5B and GEP100 was blocked, and recovered to the level of DMSO treated ([Fig. 3](#F0003){ref-type="fig"}A). Meanwhile, the cleavage of HAUSP, SDCCAG3, and PARD3 was inhibited slightly. Upon Z-DEVD-FMK and STS treatment, the cleavages of Kinesin5B, GEP100, and SDCCAG3 were inhibited completely, but HAUSP and PARD3 were still cleaved, but less than STS alone ([Fig. 3](#F0003){ref-type="fig"}A). Upon STS and Z-VAD-FMK treatment, the cleavage of all candidate proteins was inhibited completely ([Fig. 3](#F0003){ref-type="fig"}A). Accordingly, these data suggest that HAUSP, Kinesin5B, GEP100, SDCCAG3, and PARD3 are cleaved somewhat, not only by caspase-6, but also by other caspases, and their cleavages seem not to be mutually exclusive *in vivo*.

We also checked the rest of the candidates that were not cleaved directly by caspase-6, in the same way ([Fig. 3](#F0003){ref-type="fig"}B). CLK3 and ADH4 were proteolytically processed upon STS treatment, but these cleavages were slightly blocked by Z-VEID-FMK or Z-DEVD-FMK, and completely blocked by Z-VAD-FMK. Meanwhile the cleavage of MDH1 was almost completely inhibited by either Z-VEID-FMK or Z-DEVD-FMK. Taken together, CLK3, ADH4, and MDH1 are processed during apoptosis, but they are not direct substrates for caspase-6.

![Cleavage of caspase-6 substrate candidates was confirmed by *in vitro* cleavage assay. (A) HepG2 extract was incubated with active caspase-6 (10 U) or inactive capsase-6 (10 U) in the presence or absence of 30 μM Z-VEID-FMK. The reaction mixture was analyzed by immunoblotting with the specific antibodies against (A) HAUSP, Kinesin5B, GEP100, SDCCAG3, PARD3 and Lamin A/C. (B) HepG2 extract was incubated with increasing amount of active caspase-6 (5, 10, 15, 20 U) or inactive capsase-6 (20 U). The reaction mixture was analyzed by immunoblotting with the specific antibodies against CLK3, ADH4, MDH1, and Lamin A/C (Cl, cleaved Lamin A/C). Lamin A/C cleavage was used as a positive control. The asterisk indicates a nonspecific band. The representative blot of at least two independent experiments is shown. 1 U is the amount of enzyme required to cleave 1nmole of caspase substrate completely in 1 hr.](BMB-46-588-g0002){#F0002}

Among the identified caspase-6 substrates, HAUSP is a deubiquitinating enzyme that removes ubiquitin from p53 and MDM2 [@B028]. HAUSP plays a role in cell survival, proliferation and apoptosis, through regulating the p53 level [@B028]. It has been reported that HAUSP is processed in a caspase-dependent manner during thymocyte apoptosis [@B029]. In our study, we demonstrate that HAUSP is directly processed by caspase-6 in human cells, the cervical cancer cell HeLa ([Fig. 2](#F0002){ref-type="fig"}A and [3](#F0003){ref-type="fig"}A) and hepatocarcinoma cell HepG2 (data not shown), indicating that HAUSP is caspase-6 specific substrate, and is not cell type specific. Another identified caspase-6 substrate, Kinesin 5B is microtubule associated motor protein transporting vesicles along the microtubule [@B030]. It has been reported that kinectin, kinesin receptor protein, is cleaved by caspase, and the transport system becomes destroyed during apoptosis [@B031]. Based on our results, caspase-6 indeed cleaves kinesin 5B transporting cellular cargoes, as well as cytoskeletal protein, such as tubulin and actin, suggesting that caspase-6 might be involved in the disruption of intracellular vesicle transport process, by inactivating kinesin 5B.

In conclusion, we identified 34 putative caspase-6 substrates, through 2-dimesional electrophoresis/MALDI-TOF analyses. Furthermore, we confirmed that HAUSP, Kinesin 5B, GEP100, SDCCAG3 and PARD3 are directly cleaved by caspase-6 during apoptosis. These newly identified substrates seem to be involved in membrane trafficking, cell polarization, and p53 stability, suggesting that our results may provide a clue to understanding the roles of caspase-6 in apoptosis.

![Cleavage of caspase-6 substrate candidates was confirmed by *in vivo* cleavage assay. HeLa cells were treated with 1 μM STS for 24 hr in the presence or absence of the 100 μM caspase inhibitors (Z-VEID-FMK; caspase-6 inhibitor, Z-DEVD-FMK; caspase-3/-7 inhibitor, Z-VAD-FMK; pan-caspase inhibitor) pretreated to cells for 3 hr. After 24 hr, cells were harvested and lysed. Cell lysates were analyzed by immunoblotting with the specific antibodies against (A) HAUSP, Kinesin5B, GEP100, SDCCAG3, PARD3, Lamin A/C (Cl, cleaved Lamin A/C), and PARP (Cl, cleaved PARP); and (B) CLK3, ADH4, MDH1, Lamin A/C, and PARP. A coomassie blue stain of PVDF membrane was the loading control. The representative blot of at least two independent experiments is shown.](BMB-46-588-g0003){#F0003}

MATERIALS AND METHODS
=====================

Cell culture
------------

HeLa and HepG2 were maintained in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, USA), supplemented with 10% fetal bovine serum (FBS, Gibco, USA) in a humidified atmosphere of 5% CO~2~ in air, at 37℃. HepG2 cells were fractionated using Qproteome Cell Compartment Kit (QIAGEN, USA), according to the manufacture's instruction.

Antibodies and reagents
-----------------------

Anti-PARP (\#9542), anti-Lamin A/C (\#2032), and anti-HAUSP (\#3277) were purchased from Cell Signaling (USA). Anti-ADH4 (ab83819), anti-CLK3 (ab54683), anti-Kinesin5B (ab42492), anti-PARD3 (ab40769), and anti-SDCCAG3 (ab97666) were from Abcam (USA). Anti-GEP100 (G4798) was from Sigma. Anti- MDHC (sc-166879) was from Santa Cruz (USA). Staurosporine (\#1048-1) was from BioVision (CA). Z-VEID-FMK (FMK006), Z-DEVD-FMK (FMK004), and Z-VAD-FMK (FMK001) were purchased from R&D System (USA).

Cloning and mutagenesis of caspase-6
------------------------------------

Δ23 caspase-6, prodomain deleted mutant, was subcloned to pET21a(+), using *BamH* I and *Xho* I sites. This construct was mutated using the *QuikChange Site-Directed* Mutagenesis Kit (Stratagene, CA), according to the manufacture's instructions, with the following oligonucleotides: Caspase-6 Forward C163S 5'-TTTATCATTCAGGCAAGTCGGGGAAACCAGCAC-3', Caspase-6 Reverse C163S 5'-GTGCTGGTTTCCCCGACTTGCCTGAATGATAAA-3'. The constructs were confirmed by sequencing at the Solgent (Daejeon, Korea).

Expression and purification of recombinant caspase-6
----------------------------------------------------

Recombinant Δ23 caspase-6 and Δ23 caspase-6 C163S with C-terminal His-tag were expressed and purified from *E. coli* BL21 codon plus (DE3) RIL (stratagene, CA), using affinity chromatography. In brief, cells were lysed in the lysis buffer (50 mM NaH~2~PO~4~, 500 mM NaCl, pH 8.0) with 0.5% sarcosine and EDTA free protease inhibitor (Roche, Germany). The lysate was clarified by centrifuging at 13,000 rpm, 4℃ for 15min and the supernatant was incubated with Ni-NTA agarose beads (QIAGEN, USA). After extensive washing, bound proteins were eluted with the lysis buffer containing 250 mM imidazole. Protein concentration was determined by the Bradford (Bio-Rad, USA) protein assay.

2-DE analysis and MALDI-TOF-MS
------------------------------

The protein samples were dissolved in 9 M urea, 2 M thiourea, 4% CHAPS, 50 mM DTT, 0.003% bromophenol blue, and 2% IPG buffer pH3-10 (GE healthcare, USA). The dissolved samples were applied onto immobilized 18 cm, pH 3-10 gradient strips (GE healthcare, USA). Strips were rehydrated, and isoelectric focusing was performed in a stepwise fashion (0：01 h at 300 V; 1：30 h at 3,500 V; 13：00 hr at 3,500 V). After the focused strips were equilibrated with DTT and iodoacetamide equilibration solution for 15 min respectively, the second-dimensional gel electrophoresis was performed on 10% SDS-PAGE. The gels were silver-stained, using PlusOne Silver Staining Kit, Protein (GE healthcare, USA), according to the manufacturer's instructions. For mass spectrometry analysis, silver stained proteins were excised from the gels. The spots were destained and digested with trypsin, and the peptides from the spot were analyzed by MALDI-TOF, at Yonsei Proteome Research Center (Seoul, Korea). The database search was performed at The CASBAH and CutDB. The CASBAH (The CAspase Substrate DataBAse Homepage) is an online database containing all of the reported mammalian caspase substrates [@B032]. CutDB is an online proteolytic event database that provides the list of protease and corresponding substrates and cleavage sites [@B033].

In vitro cleavage assay
-----------------------

HepG2 cells were lysed using NP40 lysis buffer (137 mM NaCl, 20 mM Tris-HCl pH 8.0, 10% Glycerol, 1% NP40, 2 mM EDTA) containing protease inhibitor (Roche, Germany). Cell lysates were incubated with either recombinant Δ23 caspase-6 protein or Δ23 caspase-6 C163S protein, at 37℃ for 24 hr. Reactions were stopped by adding Laemmli buffer, and were boiled at 100℃ for 5 min.
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